Nmj. Rupniak et al., FAILURE OF INTRAVENOUS PENTAGASTRIN CHALLENGE TO INDUCE PANIC-LIKE EFFECTS IN RHESUS-MONKEYS, Neuropeptides, 25(2), 1993, pp. 115-119
We examined the ability of intravenous (i.v.) challenge with pentagast
rin to induce behavioural and cardiovascular effects consistent with p
anic attack in conscious rhesus monkeys. For behavioural evaluation, 4
naive male rhesus monkeys familiar with minimal manual restraint nece
ssary for drug administration received a rapid i.v. bolus of pentagast
rin (4, 8 or 16 mug/kg) or water on four separate occasions according
to a randomised cross-over design. Behaviour was rated by a blind obse
rver continuously during, and for the first 5 min immediately followin
g i.v. injections while the monkey sat on the handler's lap, and then
for a further 25 min in an individual observation cage. In separate ex
periments, the ability of pentagastrin to alter cardiovascular paramet
ers which may accompany panic or anxiety (elevated heart rate and bloo
d pressure) was explored. For cardiovascular studies, 8 male or female
rhesus monkeys with femoral artery catheters were chair restrained an
d received a bolus injection of pentagastrin (4, 8 or 16 mug/kg) or sa
line into the saphenous vein at 30 min intervals. Blood pressure and h
eart rate were monitored continuously using a Statham Gould pressure t
ransducer. Pentagastrin induced no consistent behavioural or cardiovas
cular changes. Similar pilot studies using CCK4 also failed to reveal
such effects. We conclude that CCK-induced panic-like effects may not
be demonstrable following challenge with pentagastrin under laboratory
conditions in rhesus monkeys.